CRYPTIVAX Trademark

Trademark Overview


On Thursday, April 3, 2025, a trademark application was filed for CRYPTIVAX with the United States Patent and Trademark Office. The USPTO has given the CRYPTIVAX trademark a serial number of 99118774. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 25, 2025. This trademark is owned by Epitopea Inc.. The CRYPTIVAX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Immunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; antigens in the nature of tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for treatment in the nature of regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins for diagnosing cancer and diseases and disorders of the immune system; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders

Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; monoclonal antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use

Research and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing scientific research information and data relating to oncology and immunology; advisory and consultancy services related to scientific research in the fields of oncology oncology and immunology
cryptivax

General Information


Serial Number99118774
Word MarkCRYPTIVAX
Filing DateThursday, April 3, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2025

Trademark Statements


Goods and ServicesImmunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; antigens in the nature of tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for treatment in the nature of regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins for diagnosing cancer and diseases and disorders of the immune system; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders
Goods and ServicesActive chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; monoclonal antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use
Goods and ServicesResearch and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing scientific research information and data relating to oncology and immunology; advisory and consultancy services related to scientific research in the fields of oncology oncology and immunology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpitopea Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB12LA
GB

Party NameEpitopea Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontreal, QC H3T1J4

Trademark Events


Event DateEvent Description
Thursday, April 3, 2025NEW APPLICATION ENTERED
Thursday, April 3, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 1, 2025ASSIGNED TO EXAMINER
Wednesday, September 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 3, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 3, 2025NON-FINAL ACTION E-MAILED